Cancer BiologybioRxivPreprint
Targeting IGF2BP1 Creates a Mitotic Vulnerability in Colorectal Carcinoma
Bruno Griesler, Sven Hagemann, Robert E. Winkler…·Stefan Hüttelmaier
This study identifies IGF2BP1 as a regulator of mitotic integrity in CRC, showing that its inhibition creates a therapeutic vulnerability that synergizes with paclitaxel.
DOI 10.64898/2026.10.22.761131